Can smart dosing beat standard care for tough infections?
NCT ID NCT05914467
First seen Feb 18, 2026 · Last updated May 09, 2026 · Updated 8 times
Summary
This study tests whether using personalized dosing (based on drug levels in the blood) helps more people with bacterial infections reach the right amount of teicoplanin compared to standard dosing. About 74 adults in hospital intensive care or other units will take part. The goal is to see if tailored dosing leads to better treatment outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
RadboudUMC
Nijmegen, 6525GA, Netherlands
Conditions
Explore the condition pages connected to this study.